Search hospitals > Illinois > Chicago
Ann & Robert H Lurie Children's Hospital of Chicago
Claim this profileChicago, Illinois 60611
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Solid Tumors
Conducts research for Relapse
1152 reported clinical trials
83 medical researchers
Summary
Ann & Robert H Lurie Children's Hospital of Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Solid Tumors, Relapse and other specialties. Ann & Robert H Lurie Children's Hospital of Chicago is involved with conducting 1,152 clinical trials across 1,412 conditions. There are 83 research doctors associated with this hospital, such as Nobuko Hijiya, MD, Amy Paller, David O. Walterhouse, and Elizabeth A. Sokol.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderBRAF positive
Stage IV
Stage II
Top PIs
Nobuko Hijiya, MDNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center8 years of reported clinical research
Expert in Cancer
Expert in Lymphoma
42 reported clinical trials
94 drugs studied
Amy PallerNorthwestern University7 years of reported clinical research
Studies Atopic Dermatitis
Studies Dermatitis
20 reported clinical trials
18 drugs studied
David O. WalterhouseLurie Children's Hospital-Chicago8 years of reported clinical research
Expert in Cancer
Expert in Osteosarcoma
19 reported clinical trials
39 drugs studied
Elizabeth A. SokolLurie Children's Hospital-Chicago4 years of reported clinical research
Studies Cancer
Studies Solid Tumors
14 reported clinical trials
33 drugs studied
Clinical Trials running at Ann & Robert H Lurie Children's Hospital of Chicago
Brain Tumor
Acute Myeloid Leukemia
Testicular cancer
Diffuse Intrinsic Pontine Glioma
Adult T-Cell Leukemia/Lymphoma
Lazy Eye
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Cancer
Wilms Tumor
DAY101 vs. Chemotherapy
for Pediatric Brain Cancer
This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Nivolumab + DAY101
for Craniopharyngioma
The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.
Recruiting1 award Phase 210 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ann & Robert H Lurie Children's Hospital of Chicago?
Where is Ann & Robert H Lurie Children's Hospital of Chicago located?
Who should I call to ask about financial aid or insurance network?
What insurance does Ann & Robert H Lurie Children's Hospital of Chicago accept?
What awards or recognition has Ann & Robert H Lurie Children's Hospital of Chicago received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.